Tofacitinib approved by FDA for Active Ankylosing Spondylitis Dr. Nandita Mohan24 Dec 2021 3:29 PM ISTThe U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ / XELJANZ XR (tofacitinib) for the...
Medical Bulletin 23/December/2021 Dr. Nandita Mohan23 Dec 2021 5:30 PM ISTHere are Top Medical stories of the dayFaster transmission of the Omicron virus and why third dose might be needed A team of researchers from Hong...
Oral tofacitinib effective for treating alopecia areata in children: Study Medha Baranwal21 Dec 2021 9:00 AM ISTUSA: A recent study in the journal Pediatric Dermatology showed oral tofacitinib to be clinically effective and well-tolerated in the majority of...
FDA Approves tofacitinib for Treatment of Active Ankylosing Spondylitis Hina Zahid20 Dec 2021 9:00 AM ISTNEW YORK - The U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ® / XELJANZ® XR...
Pfizer Xeljanz secures USFDA nod to treat active ankylosing spondylitis Ruchika Sharma15 Dec 2021 3:20 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (USFDA) has approved the supplemental New Drug Application (sNDA) for...
Tofacitinib, effective treatment for juvenile idiopathic arthritis: Lancet Medha Baranwal13 Nov 2021 3:45 AM ISTUSA: Tofacitinib, an oral Janus kinase inhibitor, is effective for the treatment of patients with polyarticular course juvenile idiopathic arthritis...
Topical JAK and PDE4 inhibitors promising treatments for Atopic dermatitis: Study MD Editorial Team22 Oct 2021 9:00 AM ISTChina: Topical Janus kinase (JAK) and phosphodiesterase-4 (PDE4) inhibitors are novel treatment approaches for atopic dermatitis (AD).A new study...
Tofacitinib and ruxolitinib show efficacy in alopecia areata: shows meta-analysis Dr Manoj Kumar Nayak15 Sept 2021 9:30 AM ISTTofacitinib and ruxolitinib show efficacy in alopecia areata: shows meta-analysis Alopecia areata is a common disorder of hair loss, treatment of...
Treatment of IBD with steroids and tofacitinib increases cholesterol levels: Study MD Editorial Team14 Sept 2021 9:00 AM ISTInflammatory bowel disease (IBD) is associated with an increased risk of cardiovascular disease however prevalence of obesity, hypertension and...
Tofacitinib shows promise in managing psoriatic arthritis, finds study Dr Satabdi Saha20 July 2021 9:00 AM ISTA recent research has suggested that in patients with PsA, pain improvements were experienced by more patients, and more rapidly, with...
Tofacitinib use in ulcerative colitis reports infrequent malignant events, finds study Dr Satabdi Saha24 Jun 2021 10:00 AM ISTTofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC).According to a recent research, under...
Tofacitinib lowers risk of death or respiratory failure in COVID-19 pneumonia: NEJM Hina Zahid18 Jun 2021 11:49 AM ISTResearchers have found in a new study that among patients hospitalized with Covid-19 pneumonia, tofacitinib led to a lower risk of death or...
